EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT06762145
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT06762145
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06762145. Randomized; single masking; primary purpose prevention. Start 2025-01-01 (anticipated); primary completion 2025-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial)
- Acronym
- EAGLE-TAVR
- Condition
- Transcatheter Aortic Valve Replacemen
- Condition
- Left Bundle Branch Block
- Intervention (Drug)
- Methylprednisolone (Corticosteroid)
- Intervention (Drug)
- Placebo
- Lead sponsor
- Xiao-dong Zhuang
Record details
- Record id
cardio:ct-nct06762145- Content hash
8997ba531c0a13eeb3be63cc6cab9b51868c392e77ad3a4ff08acca727c45d62